Atlas Trials

Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

Clinical trial NCT00991055 · UNKNOWN

Trial details

NCT number
NCT00991055
Sponsor
National Cheng-Kung University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2008-05-01
Primary completion
2010-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.